- Report
- January 2025
- 209 Pages
Global
From €4404EUR$4,995USD£3,840GBP
- Report
- November 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,581GBP
€3483EUR$3,950USD£3,037GBP
- Report
- November 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,581GBP
€3483EUR$3,950USD£3,037GBP
- Report
- November 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,581GBP
€3483EUR$3,950USD£3,037GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,581GBP
€3483EUR$3,950USD£3,037GBP
- Report
- May 2025
- 92 Pages
Global
From €3500EUR$4,253USD£3,159GBP
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,253USD£3,159GBP
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,253USD£3,159GBP
- Report
- September 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- March 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- March 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- October 2025
- 90 Pages
Global
From €4276EUR$4,850USD£3,729GBP
- Report
- July 2025
- 132 Pages
Global
From €3635EUR$4,123USD£3,170GBP
€4276EUR$4,850USD£3,729GBP
From €6612EUR$7,500USD£5,766GBP
- Report
- March 2025
- 142 Pages
Global
From €3635EUR$4,123USD£3,170GBP
€4276EUR$4,850USD£3,729GBP
- Report
- August 2025
- 150 Pages
Africa, Middle East
From €5246EUR$5,950USD£4,575GBP
- Report
- April 2025
- 120 Pages
United States
From €4320EUR$4,900USD£3,767GBP
- Report
- November 2025
- 130 Pages
Middle East
From €5246EUR$5,950USD£4,575GBP
- Report
- November 2025
- 150 Pages
Middle East
From €5246EUR$5,950USD£4,575GBP
- Report
- October 2025
- 150 Pages
United States
From €5246EUR$5,950USD£4,575GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more